ARTICLE | Company News
Insmed Pharmaceuticals other research news
March 22, 1999 8:00 AM UTC
Insmed received a $747,000 Phase II SBIR grant from the National Institute of Child Health and Human Development to evaluate the efficacy of INS-1 to treat PCOS. ...